130 Participants Needed

EEG Biomarkers for Chronic Lower Back Pain

OA
Overseen ByOmar Altirkawi
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Picture Viewing EEG, Resting State EEG, Electroencephalogram, EEG, Resting-State EEG, Stop Signal EEG for chronic lower back pain?

Research suggests that changes in brain activity, as measured by EEG, are linked to improvements in chronic low back pain when using psychological treatments like mindfulness and cognitive therapy. These treatments can alter brain oscillations, which may help reduce pain.12345

Is EEG safe for use in humans?

EEG (electroencephalogram) is generally considered safe for use in humans as it is a non-invasive method that records brain activity without causing discomfort or harm.678910

How is the EEG treatment for chronic lower back pain different from other treatments?

This treatment is unique because it uses EEG (electroencephalogram) to identify brain activity patterns associated with chronic lower back pain, potentially offering a non-invasive way to understand and treat the condition by focusing on brain mechanisms rather than just the spine.13101112

What is the purpose of this trial?

Chronic low back pain (CLBP) is a pervasive disorder affecting up to one-fifth of adults globally and is the single greatest cause of disability worldwide. Despite the high prevalence and detrimental impact of CLBP, its treatments and mechanisms remain largely unclear. Biomarkers that predict symptom progression in CLBP support precision-based treatments and ultimately aid in reducing suffering. Longitudinal brain-based resting-state neuroimaging of patients with CLBP has revealed neural networks that predict pain chronification and its symptom progression. Although early findings suggest that measurements of brain networks can lead to the development of prognostic biomarkers, the predictive ability of these models is strongest for short-term follow-up. Measurements of different neural systems may provide additional benefits with better predictive power.Emotional and cognitive dysfunction is common in CLBP, occurring at the behavioral and cerebral level, presenting a unique opportunity to detect prognostic brain-based biomarkers. Likewise, improvements in electroencephalogram (EEG) neuroimaging strategies have led to increased spatial resolution, enabling researchers to overcome the limitations of classically used neuroimaging modalities (e.g., magnetic resonance imaging \[MRI\] and functional MRI), such as high cost and limited accessibility. Using longitudinal EEG, this patient-oriented research project will provide a comprehensive neural picture of emotional, cognitive, and resting-state networks in patients with CLBP, which will aid in predicting symptom progression in CLBP. Through this award, the investigators will use modern EEG source analysis strategies to track biomarkers at baseline and 1- and 2-month follow-ups and their covariance with markers for pain and emotional and cognitive dysfunction. A 5-month follow up will also be used to only assess patient reported outcomes. In Aim 1, the investigators will identify and characterize differences in resting-state, emotional, and cognitive networks between patients with CLPB and age/sex-matched controls. In Aim 2, the investigators will identify within-subject changes across time and their relationship with clinical symptoms. In Aim 3, as an exploratory aim, the investigators will apply machine- and deep-learning strategies to detect a comprehensive signature of CLBP using EEG features from resting-state, emotional, and cognitive networks.

Eligibility Criteria

This trial is for adults with chronic low back pain (CLBP) who can speak English. It's not suitable for individuals with cancer, severe psychiatric conditions, those involved in injury litigation or receiving workers' compensation benefits.

Inclusion Criteria

I have been diagnosed with chronic low back pain.

Exclusion Criteria

Severe psychiatric conditions
Pending personal litigation relating to an injury or receiving workers' compensation benefits
Being a non-English speaker.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Baseline EEG and neuropsychological assessments are conducted

1 week
1 visit (in-person)

Follow-up

Participants undergo EEG and neuropsychological assessments at 1-month and 2-month follow-ups

2 months
2 visits (in-person)

Extended Follow-up

Participants are assessed for patient-reported outcomes at a 5-month follow-up

3 months
1 visit (in-person)

Treatment Details

Interventions

  • Picture Viewing EEG
  • Resting State EEG
  • Stop Signal EEG
Trial Overview The study tests if EEG-based biomarkers can predict the progression of CLBP symptoms. Participants will undergo EEGs to track brain activity related to resting state, emotions, and cognition at baseline and then after 3 and 6 months.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment3 Interventions
All participants will complete all interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

Trials
508
Recruited
1,090,000+

Findings from Research

A study involving 57 adults with chronic low back pain found that psychological treatments like cognitive therapy, mindfulness meditation, and mindfulness-based cognitive therapy significantly reduced theta and alpha brain wave activity, indicating changes in brain function associated with pain management.
All treatments led to a reduction in beta power across multiple brain regions, with a specific link between reduced beta power in the central region and decreased pain intensity observed only in mindfulness-based cognitive therapy, suggesting that these psychological approaches can effectively alter brain activity related to pain perception.
Change in Brain Oscillations as a Mechanism of Mindfulness-Meditation, Cognitive Therapy, and Mindfulness-Based Cognitive Therapy for Chronic Low Back Pain.Day, MA., Matthews, N., Mattingley, JB., et al.[2022]
In a study involving 50 chronic low back pain (cLBP) patients and 44 healthy controls, abnormal functional connectivity (FC) in specific brain regions was identified, particularly in the medial prefrontal cortex and rostral anterior cingulate cortex, which correlated with pain duration and severity.
The study demonstrated that resting-state functional connectivity could accurately distinguish cLBP patients from healthy controls with 91% accuracy in the initial cohort, suggesting that these brain connectivity patterns may play a crucial role in understanding and managing chronic pain.
Abnormal medial prefrontal cortex functional connectivity and its association with clinical symptoms in chronic low back pain.Tu, Y., Jung, M., Gollub, RL., et al.[2022]
Chronic low back pain (LBP) is associated with significant changes in brain structure and connectivity, as shown by differences in cortical thickness and resting-state functional connectivity in a study of 24 LBP patients compared to 27 healthy controls.
Machine learning analysis of cortical thickness data achieved a classification accuracy of 74.51%, suggesting that these brain changes could serve as biomarkers to help guide more effective treatments for LBP.
Multi-modal biomarkers of low back pain: A machine learning approach.Lamichhane, B., Jayasekera, D., Jakes, R., et al.[2021]

References

Change in Brain Oscillations as a Mechanism of Mindfulness-Meditation, Cognitive Therapy, and Mindfulness-Based Cognitive Therapy for Chronic Low Back Pain. [2022]
Abnormal medial prefrontal cortex functional connectivity and its association with clinical symptoms in chronic low back pain. [2022]
Multi-modal biomarkers of low back pain: A machine learning approach. [2021]
S1 is associated with chronic low back pain: a functional and structural MRI study. [2021]
Are Functional Brain Alterations Present in Low Back Pain? A Systematic Review of EEG Studies. [2021]
Is There a Difference in EEG Characteristics in Acute, Chronic, and Experimentally Induced Musculoskeletal Pain States? a Systematic Review. [2023]
Low Back Pain Assessment Based on Alpha Oscillation Changes in Spontaneous Electroencephalogram (EEG). [2022]
Effects of experimentally induced low back pain on the sit-to-stand movement and electroencephalographic contingent negative variation. [2021]
The low-frequency BOLD signal oscillation response in the insular associated to immediate analgesia of ankle acupuncture in patients with chronic low back pain. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Does baseline EEG activity differ in the transition to or from a chronic pain state? A longitudinal study. [2023]
Functional Disruptions of the Brain in Low Back Pain: A Potential Imaging Biomarker of Functional Disability. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Electroencephalographic Patterns in Chronic Pain: A Systematic Review of the Literature. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security